The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSIG Regulatory News (SHI)

Share Price Information for SIG (SHI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 26.50
Bid: 26.35
Ask: 26.50
Change: 0.25 (0.95%)
Spread: 0.15 (0.569%)
Open: 25.50
High: 27.15
Low: 25.50
Prev. Close: 26.25
SHI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

18 Sep 2015 09:44

RNS Number : 4973Z
SIG PLC
18 September 2015
 



SIG plc

18 September 2015

Ordinary Shares of 10p each

 

SIG plc (the "Company") announces that on 17 September 2015 it granted awards in the UK over ordinary shares in the Company in connection with the SIG plc 2014 Long Term Incentive Plan ("LTIP").

 

Pursuant to DTR 3.1.4 and following notifications received on 17 September 2015 in fulfilment of the obligations imposed by DTR 3.1.2 we hereby announce that the following awards have been granted to PDMRs.

 

Director/PDMR

Position

2015 LTIP

Award

Exercise Price (pence)

Total number of shares over which awards now held

Mr S R Mitchell

 

Group Chief Executive

455,838

NIL

1,392,440

Mr D G Robertson

Group Finance Director

274,323

NIL

908,982

Mrs L H Kennedy-McCarthy

Group HR Director

142,977

NIL

287,207

Mr R T Barclay

 

Managing Director -

UK & Ireland

169,074

NIL

511,230

Mr M Pearson

 

Group Chief Information Officer

95,264

NIL

146,932

Mr L Lvovich

Corporate Development Director

103,429

NIL

103,429

 

The awards take the form of nil cost options, being an option under the LTIP, with a nil exercise price.

 

Subject to the rules of the LTIP and the satisfaction of the performance conditions detailed below, the earliest vesting date of the award is normally 16 September 2018.

 

 

The performance conditions subject to which the options have been granted are as follows:

 

1. Two thirds of the award is subject to a condition as to the average return on capital employed (ROCE) over the Performance Period (the "ROCE Tranche"). The period over which the ROCE performance condition will be measured will be the period of three financial years 31 December 2015, 2016 and 2017.

Average Return on Capital Employed (ROCE) for FY2015-2017

% of ROCE Tranche vesting

11% or less

Nil

Above 11% but less than 14%

Between 0% and 100% on astraight-line basis

14% and above

100%

 

2. The remaining one third of the award is subject to a condition as to the cumulative underlying earnings per share (EPS) over the Performance Period (the "EPS Tranche"). The period over which the EPS performance condition will be measured will be the period of three financial years 31 December 2015, 2016 and 2017.

Cumulative Underlying EPS forFY2015-2017

% of EPS Tranche vesting

Less than 38 pence

Nil

38 pence to 48 pence

25% to 100% on astraight-line basis

Above 48 pence

100%

 

 

R C Monro

Company Secretary 0114 285 6355

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSSFESAAFISELU
Date   Source Headline
2nd May 20241:53 pmRNSResult of AGM
2nd May 20247:00 amRNSTrading Update
12th Apr 20244:01 pmRNSDirector/PDMR Shareholding
4th Apr 202410:12 amRNSDirector/PDMR Shareholding
25th Mar 202410:21 amRNSNotice of AGM
22nd Mar 202410:30 amRNSDirector/PDMR Shareholding
22nd Mar 202410:12 amRNSDirector/PDMR Shareholding
5th Mar 202412:14 pmRNSAnnual Financial Report
5th Mar 20247:00 amRNSFull year results for year ended 31 December 2023
9th Jan 20247:00 amRNS2023 Full Year Trading Update
1st Dec 20235:42 pmRNSDirector/PDMR Shareholding
23rd Nov 20239:00 amRNSCapital Markets Event
13th Nov 20239:00 amRNSNotice of Capital Markets Event
13th Oct 20233:51 pmRNSHolding(s) in Company
12th Oct 20237:00 amRNSQ3 Trading Update
25th Sep 20233:56 pmRNSDirectorate Change
9th Aug 20234:58 pmRNSHolding(s) in Company
8th Aug 20237:00 amRNSHalf-year Report
12th Jul 20234:26 pmRNSHolding(s) in Company
11th Jul 20234:06 pmRNSHolding(s) in Company
11th Jul 202310:58 amRNSHolding(s) in Company
10th Jul 202311:09 amRNSHolding(s) in Company
5th Jul 20233:15 pmRNSHolding(s) in Company
5th Jul 20237:00 amRNSH1 Trading Update
4th May 20232:32 pmRNSResult of AGM
4th May 20237:00 amRNSTrading Update
31st Mar 202312:47 pmRNSHolding(s) in Company
27th Mar 202310:30 amRNSNotice of AGM
13th Mar 20233:49 pmRNSDirector/PDMR Shareholding
13th Mar 20233:39 pmRNSDirector/PDMR Shareholding
13th Mar 202310:36 amRNSHolding(s) in Company
9th Mar 20237:00 amRNSDirector/PDMR Shareholding
8th Mar 20231:20 pmRNSAnnual Financial Report
8th Mar 20237:01 amRNSDirectorate Changes
8th Mar 20237:00 amRNSFull year results for the year ended 31 Dec 2022
27th Feb 202311:20 amRNSDirector Declaration
1st Feb 20237:00 amRNSDirectorate Change
10th Jan 20237:00 amRNS2022 Full Year Trading Update
16th Dec 20228:04 amRNSDirector Declaration
15th Sep 202210:49 amRNSDirectorate Changes
13th Sep 20224:59 pmRNSDirector/PDMR Shareholding
8th Sep 20227:00 amRNSCEO Steve Francis to be succeeded by Gavin Slark
9th Aug 20227:00 amRNSHalf-year Report
25th Jul 20227:00 amRNSAcquisition of Miers Construction Products Limited
1st Jul 20229:38 amRNSNotice of Half Year Results
22nd Jun 20229:53 amRNSChange of Adviser
12th May 20226:11 pmRNSResult of AGM
12th May 20222:52 pmRNSResult of AGM
29th Apr 20227:00 amRNSTrading Update
12th Apr 20223:21 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.